Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Bastarrachea J, Hortobagyi GN, Smith TL, Kau SWC, Buzdar AU (1994) Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast-cancer. Ann Intern Med 120(1):18–25
2. Kroenke CH, Chen WY, Rosner B, Holmes MD (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23(7):1370–1378
3. Obermair A, Kurz C, Hanzal E, Bancher-Todesca D, Thoma M, Bodisch A, Kubista E, Kyral E, Kaider A, Sevelda P et al (1995) The influence of obesity on the disease-free survival in primary breast cancer. Anticancer Res 15(5B):2265–2269
4. Bonsang-Kitzis H, Chaltier L, Belin L, Savignoni A, Rouzier R, Sablin MP, Lerebours F, Bidard FC, Cottu P, Sastre-Garau X et al: Beyond axillary lymph node metastasis, BMI and menopausal status are prognostic determinants for triple-negative breast cancer treated by neoadjuvant chemotherapy. Plos One 2015, 10(12)
5. Jeon YW, Kang SH, Park MH, Lim W, Cho SH, Suh YJ: Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival. BMC Cancer 2015, 15
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献